How NOVA Is Turning Decentralized AI Into Real-World Drug Discovery on Bittensor
Decentralized AI is often framed as an alternative to centralized research labs, but in practice most systems struggle to move beyond theory. Benchmarks are published, models are trained, and incentives are discussed, yet the gap between virtual results and real-world impact remains wide. NOVA, a decentralized drug discovery platform built on Bittensor, is attempting to…